Literature DB >> 31019797

Exceptional antitumor responses beyond immune checkpoint inhibition in non-small cell lung cancer patients: insights into optimal therapy sequencing.

Andriani Charpidou1, Ioannis Vathiotis1, Ioannis Gkiozos1, Konstantinos Syrigos1.   

Abstract

Entities:  

Year:  2019        PMID： 31019797      PMCID： PMC6462730          DOI： 10.21037/jtd.2019.02.38

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  1 in total

1.  Real-World Treatment Patterns and Outcomes Among Patients With Metastatic NSCLC Previously Treated With Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors.

Authors:  Savreet Bains; Anu Kalsekar; Katayoun I Amiri; Jared Weiss
Journal:  JTO Clin Res Rep       Date:  2022-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.